Medifast, Inc. (MED)
NYSE: MED · Real-Time Price · USD
12.45
-0.03 (-0.24%)
May 18, 2026, 4:00 PM EDT - Market closed

Medifast Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
-20.02-18.672.0999.42143.57164.03
Depreciation & Amortization
14.4514.2412.7113.1110.986.81
Stock-Based Compensation
7.617.647.368.1911.059.9
Other Adjustments
11.8213.4612.066.677.321.45
Changes in Inventories
17.9622.1912.1764.2761.19-126.65
Changes in Accounts Payable
-19.37-23.91-34.99-35.71-37.5954.38
Changes in Income Taxes Payable
-7.94-6.610.21-9.161.37-0.95
Changes in Other Operating Activities
-0.61-1.482.870.87-3.32-14.43
Operating Cash Flow
3.726.8624.48147.66194.5794.55
Operating Cash Flow Growth
-81.96%-71.96%-83.42%-24.11%105.80%-34.88%
Capital Expenditures
-5.19-5.61-7.45-6.48-16.68-34.21
Sale of Property, Plant & Equipment
3.64-----
Purchases of Investments
-118.74-84.41-46.6-59.76--
Proceeds from Sale of Investments
97.2882.0927.535.195.275.15
Investing Cash Flow
-23.01-7.93-26.52-61.05-11.41-29.06
Issuance of Common Stock
--0.040.19-0.81
Repurchase of Common Stock
-0.81-0.37-0.84-6.96-127.96-62.09
Net Common Stock Issued (Repurchased)
-0.81-0.37-0.8-6.77-127.96-61.28
Common Dividends Paid
-0.09-0.2-0.72-73.02-71.62-63.86
Financing Cash Flow
-0.9-0.56-1.52-79.79-199.58-125.13
Effect of Exchange Rate Changes on Cash and Cash Equivalents
000.05-0.07-0.070.11
Net Cash Flow
-20.19-1.63-3.516.75-16.49-59.54
Free Cash Flow
-1.471.2517.02141.17177.8960.34
Free Cash Flow Growth
--92.66%-87.94%-20.64%194.83%-56.69%
FCF Margin
-0.43%0.32%2.83%13.17%11.13%3.95%
Free Cash Flow Per Share
-0.130.111.5512.9315.785.11
Levered Free Cash Flow
-20.72-19.85-2.4126.32159.5248.99
Unlevered Free Cash Flow
-40.82-48.24-2.9124.47160.149.07
Updated May 4, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q